case-studies/
15 pages · Updated July 25, 2026
Pages
- Not Found
- VeriSIM Accelerating SUD Therapy Discovery with AI/ML Driven BBB Permeability Predictions │ Drug Discovery & Development Technology
- VeriSIM Pathways for Successful AI Adoption in Drug Development │ Drug Discovery & Development Technology
- VeriSIM AI-Generated Virtual Patients Enhance Clinical Trial Outcomes: a Diabetes Treatment Analysis │ Drug Discovery & Development Technology
- VeriSIM Preempting a Clinical Dead End with Metabolite Analysis Powered by Hybrid AI │ Drug Discovery & Development Technology
- VeriSIM Frost & Sullivan Report: AI-enabled Preclinical Development, VeriSIM Life │ Drug Discovery & Development Technology
- VeriSIM Optimizing Dosing with AI/ML Driven Transdermal Drug Permeation Simulation │ Drug Discovery & Development Technology
- VeriSIM NIH Human-Based Research Toolkit: Unlocking Predictive Power, Reducing Costs, and Accelerating Translation │ Drug Discovery & Development Technology
- VeriSIM BIOiSIM™ Drug Decision Engine: Breakthrough Intelligence to De-risk R&D Translation, Without Disruption │ Drug Discovery & Development Technology
- VeriSIM Predicting Translatable Drug Combinations for ADCs - A Pharma Partner Case Study │ Drug Discovery & Development Technology
- VeriSIM Predicting Patient-Specific Drug Bioavailability with AI │ Drug Discovery & Development Technology
- VeriSIM AtlasGen Novel Drug Designer: Design Clinical Success Into New Drug Discovery from Day One │ Drug Discovery & Development Technology
- VeriSIM Complex Organ Toxicity: Hybrid AI Provides Superior Prediction Accuracy with Very Limited Data │ Drug Discovery & Development Technology
- VeriSIM How to Evolve from Traditional Model-Informed Drug Discovery & Development to an AI-Informed Approach │ Drug Discovery & Development Technology
- VeriSIM Case Studies & White Papers │ Drug Discovery & Development Technology